Literature DB >> 23157436

Drug side-effect prediction based on the integration of chemical and biological spaces.

Yoshihiro Yamanishi1, Edouard Pauwels, Masaaki Kotera.   

Abstract

Drug side-effects, or adverse drug reactions, have become a major public health concern and remain one of the main causes of drug failure and of drug withdrawal once they have reached the market. Therefore, the identification of potential severe side-effects is a challenging issue. In this paper, we develop a new method to predict potential side-effect profiles of drug candidate molecules based on their chemical structures and target protein information on a large scale. We propose several extensions of kernel regression model for multiple responses to deal with heterogeneous data sources. The originality lies in the integration of the chemical space of drug chemical structures and the biological space of drug target proteins in a unified framework. As a result, we demonstrate the usefulness of the proposed method on the simultaneous prediction of 969 side-effects for approved drugs from their chemical substructure and target protein profiles and show that the prediction accuracy consistently improves owing to the proposed regression model and integration of chemical and biological information. We also conduct a comprehensive side-effect prediction for uncharacterized drug molecules stored in DrugBank and confirm interesting predictions using independent information sources. The proposed method is expected to be useful at many stages of the drug development process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157436     DOI: 10.1021/ci2005548

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  29 in total

1.  Using Drug Similarities for Discovery of Possible Adverse Reactions.

Authors:  Emir Muñoz; Vít Nováček; Pierre-Yves Vandenbussche
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Predicting Adverse Drug Effects from Literature- and Database-Mined Assertions.

Authors:  Mary K La; Alexander Sedykh; Denis Fourches; Eugene Muratov; Alexander Tropsha
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

3.  Exploring the relationship between drug side-effects and therapeutic indications.

Authors:  Ping Zhang; Fei Wang; Jianying Hu; Robert Sorrentino
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

4.  Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach.

Authors:  Tianyun Liu; Russ B Altman
Journal:  J Chem Inf Model       Date:  2015-07-16       Impact factor: 4.956

5.  FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules.

Authors:  Hongyi Zhou; Hongnan Cao; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2018-10-16       Impact factor: 4.956

6.  SuperPred: update on drug classification and target prediction.

Authors:  Janette Nickel; Bjoern-Oliver Gohlke; Jevgeni Erehman; Priyanka Banerjee; Wen Wei Rong; Andrean Goede; Mathias Dunkel; Robert Preissner
Journal:  Nucleic Acids Res       Date:  2014-05-30       Impact factor: 16.971

7.  Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches.

Authors:  Betül Güvenç Paltun; Hiroshi Mamitsuka; Samuel Kaski
Journal:  Brief Bioinform       Date:  2021-01-18       Impact factor: 11.622

8.  MEDICASCY: A Machine Learning Approach for Predicting Small-Molecule Drug Side Effects, Indications, Efficacy, and Modes of Action.

Authors:  Hongyi Zhou; Hongnan Cao; Lilya Matyunina; Madelyn Shelby; Lauren Cassels; John F McDonald; Jeffrey Skolnick
Journal:  Mol Pharm       Date:  2020-04-13       Impact factor: 4.939

9.  Integrative relational machine-learning for understanding drug side-effect profiles.

Authors:  Emmanuel Bresso; Renaud Grisoni; Gino Marchetti; Arnaud Sinan Karaboga; Michel Souchet; Marie-Dominique Devignes; Malika Smaïl-Tabbone
Journal:  BMC Bioinformatics       Date:  2013-06-26       Impact factor: 3.169

10.  2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib.

Authors:  Bjoern-Oliver Gohlke; Tim Overkamp; Anja Richter; Antje Richter; Peter T Daniel; Bernd Gillissen; Robert Preissner
Journal:  BMC Bioinformatics       Date:  2015-09-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.